Cross-cultural difference and validation of the Chinese version of Montreal Cognitive Assessment in older adults residing in Eastern China: Preliminary findings

Archives of Gerontology and Geriatrics

Volumn 56, Issue 1, 2013, Pages 38-43

  Hu, Jian bo ^a   Zhou, Wei hua ^a   Hu, Shao hua ^a   Huang, Man li ^a   Wei, Ning ^a   Qi, Hong li ^a   Huang, Jin wen ^a   Xu, Yi ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cultural differences; Mild cognitive impairment; MMSE; Montreal Cognitive Assessment; Screening; Validity

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CHINA; CHINESE; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; CULTURAL FACTOR; EARLY DIAGNOSIS; FEMALE; HUMAN; INTERNAL CONSISTENCY; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MONTREAL COGNITIVE ASSESSMENT; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOMETRY; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; TEST RETEST RELIABILITY; VALIDATION PROCESS;

AGE FACTORS; AGED; ALZHEIMER DISEASE; CHINA; COGNITION DISORDERS; CROSS-CULTURAL COMPARISON; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEX FACTORS;

EID: 84869502564     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2012.05.008     Document Type: Article

References (27)

1. Cumming T.B., Bernhardt J., Linden T. The Montreal cognitive assessment: Short cognitive evaluation in a large stroke trial. Stroke September 2011, 42:2642-2644.
2. Damian A.M., Jacobson S.A., Hentz J.G. The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: Item analyses and threshold scores. Dementia and Geriatric Cognitive Disorders 2011, 31:126-131.
3. Dong Y., Sharma V.K., Chan B.P., Venketasubramanian N., Teoh H.L., Seet R.C., et al. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. Journal of the Neurological Sciences 2010, 299:15-18.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, IV-TR 2000, American Psychiatric Association, Washington, DC.
5. Elia L.F.D., Satz P., Uchiyama C.L., White T. Color Trails Test Professional Manual 1996, Psychological Assessment Resources, Inc., Florida.
6. Freitas S., Simões M.R., Alves L., Santana I. Montreal Cognitive Assessment (MoCA): Normative study for the Portuguese population. Journal of Clinical and Experimental Neuropsychology November 2011, 33:989-996.
7. Fujiwara Y., Suzuki H., Yasunaga M., Sugiyama M., Ijuin M., Sakuma N., et al. Brief screening tool for mild cognitive impairment in older Japanese: Validation of the Japanese version of the Montreal Cognitive Assessment. Geriatrics & Gerontology International 2010, 10:225-232.
8. Gauthier S., Reisberg B., Zaudig M., Petersen R.C., Ritchie K., Broich K., et al. Mild cognitive impairment. Lancet 2006, 367:1262-1270.
9. Gaviria M., Pliskin N., Kney A. Cognitive impairment in patients with advanced heart failure and its implications on decision-making capacity. Congestive Heart Failure July 2011, 17:175-179.
10. Gill D.J., Freshman A., Blender J.A., Ravina B. The Montreal cognitive assessment as a screening tool for cognitive impairment in Parkinson's disease. Movement Disorders 2008, 23:1043-1046.
11. Hanley J., McNeil B. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843.
12. Hansson O., Zetterberg H., Buchhave P., Londos E., Blennow K., Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study. Lancet Neurology 2006, 5:228-234.
13. Larner A.J. Screening utility of the Montreal Cognitive Assessment (MoCA): In place of - oras well as - the MMSE?. International Psychogeriatrics October 2011, 3:1-6.
14. Lee J.Y., Dong W.L., Cho S.J., Na D.L., Hong J.J., Maeng J.C. Brief screening for mild cognitive impairment in elderly outpatient clinic: Validation of the Korean version of the Montreal Cognitive Assessment. Journal of Geriatric Psychiatry and Neurology 2008, 21:104-110.
15. Levey A., Lah J., Goldstein F., Steenland K., Bliwise D. Mild cognitive impairment: An opportunity to identify patients at high risk for progression to Alzheimer's disease. Clinical Therapeutics 2006, 28:991-1001.
16. Luis Cheryl A., Keegan Andrew P., Mullan Michael Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. International Journal of Geriatric Psychiatry 2009, 24:197-201.
17. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
18. Nasreddine Z.S., Phillips N.A., Bédirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society 2005, 53:695-699.
19. Nazem S., Siderowf A.D., Duda J.E., Have T.T., Colcher A., Weintraub D. Montreal Cognitive Assessment performance in patients with Parkinson's disease with " normal" global cognition according to mini-mental state examination score. Journal of the American Geriatrics Society 2009, 57:304-308.
20. Olson R.A., Chhanabhai T., McKenzie M. Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases. Supportive Care in Cancer 2008, 16:1273-1278.
21. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., DeKosky S.T. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:1133-1142.
22. Popovic I.M., Seric V., Demarin V. Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease. Journal of the Neurological Sciences 2007, 257:185-193.
23. Ritchie K., Artero S., Touchon J. Classification criteria for mild cognitive impairment: A population-based validation study. Neurology 2001, 56:37-42.
24. Sweet L., Van Adel M., Metcalf V., Wright L., Harley A., Leiva R., et al. The Montreal Cognitive Assessment (MoCA) in geriatric rehabilitation: Psychometric properties and association with rehabilitation outcomes. International Psychogeriatrics December 2011, 23:1582-1591.
25. Videnovic A., Bernard B., Fan W., Jaglin J., Leurgans S., Shannon K.M. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease. Movement Disorders 2010, 25:401-404.
26. Wen H.B., Zhang Z.X., Niu F.S., Li L. The application of Montreal cognitive assessment in urban Chinese residents of Beijing. Zhonghua Nei Ke Za Zhi 2008, 47:36-39.
27. Wong A., Xiong Y.Y., Kwan P.W., Chan A.Y., Lam W.W., Wang K., et al. The validity, reliability and clinical utility of the Hong Kong Montreal Cognitive Assessment (HK-MoCA) in patients with cerebral small vessel disease. Dementia and Geriatric Cognitive Disorders 2009, 28:81-87.